Account
Swarovski awards global media business to Havas Media
MUMBAI: Swarovski, leader in precision cut crystal jewellery, has awarded its global media business to Havas Media.
Spanning across over 35 countries including India with a key focus on US, China, UK, Italy, France, Germany, Hong Kong, Korea, Australia, Canada, Spain, Mexico and Brazil, the account will cover the full range of media including social and programmatic. Havas Media will take over responsibilities from incumbent agency Zenith Optimedia from January 1, 2017.
Swarovski Communication & Media CGB SVP branding Alessandro Vergano commented saying, “As part of our commitment to the ongoing improvement of our media and marketing governance, Swarovski periodically evaluates all marketing service suppliers to ensure we maintain the best working relationships with the best agency partners. The team at Havas Media impressed us with their responsible, yet imaginative and passionate approach – characteristics that are core to our company‘s culture.”
Havas Media Group global MD Dominique Delport added, “From the start we knew we had found something special – it was more than chemistry – it was a shared vision and passion. It was also clear we have a mutual focus on digital transformation. We know how important it is to keep the value that Swarovski has built up since 1895, but to also keep moving forward so that Swarovski can continue to design and deliver for the future. I know Swarovski will become one of our most valued long-term partners and we cannot wait to get started.”
“Swarovski has enjoyed working with Zenith Optimedia over the last 9 years and thanks them for their commitment to great work over this time” said Alessandro Vergano, Senior Vice President Branding, Communication & Media CGB, Swarovski.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
